You have been chosen to receive this valuable information.

Lubrizol Life Science Health Feasibility Programs Accelerate Product Development

The CDMO Division of Lubrizol Life Science Health (LLS Health) regularly receives inquiries on:

Overcoming poor solubility and bioavailability
Developing long-acting dosage forms
Increasing the lifespan of implantable products

To help address these issues or opportunities, we are now offering feasibility programs designed to accelerate product development in these focus areas.

These programs utilize trusted technologies to provide early-stage support in relatively quick, cost-effective packages. If the development program proves successful, LLS Health is positioned to provide ongoing optimization, scale-up, and manufacturing for each product type.

Learn More About LLS Health's Feasibility Programs

Program Spotlight: Microsphere Feasibility for Long-Acting Injectables

Long-acting depot injections are high-value products that offer an appealing route to improved patient compliance, enabling drug delivery for weeks or months at a time.

LLS Health's 12-week program allows you to quickly and easily evaluate microsphere technology for your API.

Generate Microsphere Data in 12 Weeks

Learn More about the Lyophilization of Complex Drug Products

Lyophilization (also known as freeze drying) is a process in which a liquid is converted to a solid through sublimation and desorption of water or other solvents. It is often used to stabilize active pharmaceutical ingredients (APIs) and formulations that are not stable in liquid or frozen form. Because lyophilization does not require heat, it is an ideal drying method for thermally sensitive APIs and biologics, such as proteins and peptides.

Discover more about lyophilization in this technical brief from LLS Health team that highlights:

Lyophilization Equipment and Components
The Lyophilization Process & Scale-up
Formulating Products for Lyophilization

Download the LLS Health Lyophilization Tech Brief

News and Links

LLS Health Proprietary Technologies

The Guide to Analytical Method Development

Nanomilling: Shaping the Solubility and Bioavailability of Today's Therapeutics

How Personalized Medicine is Evolving the CDMO Landscape

The Demands of the Perfect Dose

Aseptic Manufacturing and Sterile Fill-Finish for Complex Drug Products

Particle Sciences becomes Lubrizol Life Science Health

Women's Equality Day: Pharma is Leveling the Playing Field

Lyophilization of Pharmaceuticals: An Overview

Overcoming Complexity: Trends Shaping The Drug Formulation Industry

Lubrizol Acquires Bavaria Medizin Technologie GmbH

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.